Escitalopram tolerability as mono- versus augmentative therapy in patients with affective disorders: a naturalistic study

BACKGROUND: Escitalopram is a selective serotonin reuptake inhibitor, widely used in the treatment of affective disorders. The purpose of this study was to examine its safety and tolerability, as mono- versus augmentative therapy, in a group of patients with affective disorders. MATERIALS AND METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Dell’Osso, Bernardo, Arici, Chiara, Dobrea, Cristina, Camuri, Giulia, Benatti, Beatrice, Altamura, A Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573802/
https://www.ncbi.nlm.nih.gov/pubmed/23429980
http://dx.doi.org/10.2147/NDT.S39322

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573802/
https://www.ncbi.nlm.nih.gov/pubmed/23429980
http://dx.doi.org/10.2147/NDT.S39322

Ejemplares similares